Table 3.
In‐Hospital and 30‐Day Clinical Outcomes
| Variables | Angiography‐Guided (122) | FFR‐Guided (94) | P Value |
|---|---|---|---|
| Death, n (%) | 6 (4.9%) | 1 (1%) | 0.40 |
| Cardiac death, n (%) | 4 (3.3%) | 0 | 0.25 |
| Type 4a MI, n (%) | 7 (5.7%) | 3 (3.2%) | 0.12 |
| Type 1 MI, n (%) | 1 (0.8%) | 0 | 0.34 |
| Urgent PCI, n (%) | 0 | 0 | ··· |
| New elective PCI, n (%) | 0 | 0 | ··· |
| Stroke, n (%) | 2 (1.6%) | 0 | 0.12 |
| AKI stage 2 to 3, n (%) | 4 (3.3%) | 3 (3.2%) | 0.87 |
| LT bleeding, n (%) | 4 (3.3%) | 3 (3.2%) | 0.87 |
| MVC, n (%) | 12 (9.8%) | 4 (4.3%) | 0.18 |
Categorical data are presented as numbers and percentages. AKI indicates acute kidney injury; LT, life‐threatening; MI, myocardial infarction; MVC, major vascular complications; PCI, percutaneous coronary intervention.